|
G |
Acp2 |
acid phosphatase 2, lysosomal |
multiple interactions affects expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein phenanthrene affects the expression of ACP2 protein |
CTD |
PMID:28803881 |
|
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases activity affects binding |
EXP ISO |
phenanthrene binds to and results in increased activity of AHR protein phenanthrene results in increased activity of AHR protein [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; [phenanthrene co-treated with naphthalene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [pyrene co-treated with phenanthrene] inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; phenanthrene inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein] phenanthrene binds to AHR protein |
CTD |
PMID:3024361 PMID:12850102 PMID:17665671 PMID:28710019 PMID:29502740 PMID:30980910 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein] |
CTD |
PMID:28710019 PMID:30980910 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation |
ISO |
phenanthrene results in increased phosphorylation of AKT1 protein |
CTD |
PMID:34453960 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO |
phenanthrene results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:32890658 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Ar |
androgen receptor |
affects binding multiple interactions |
EXP ISO |
phenanthrene analog binds to AR protein phenanthrene analog inhibits the reaction [Androgens binds to AR protein]; phenanthrene analog inhibits the reaction [Metribolone binds to AR protein]; phenanthrene inhibits the reaction [Metribolone binds to AR protein] [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; phenanthrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenanthrene inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] |
CTD |
PMID:3695475 PMID:6323860 PMID:26022396 PMID:30980910 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA |
CTD |
PMID:28710019 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of BAX protein phenanthrene affects the expression of BAX protein |
CTD |
PMID:28803881 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Becn1 |
beclin 1 |
multiple interactions decreases expression |
ISO |
Sirolimus inhibits the reaction [phenanthrene results in decreased expression of BECN1 mRNA] |
CTD |
PMID:34453960 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CASP3 protein phenanthrene results in increased expression of CASP3 protein |
CTD |
PMID:28803881 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
increases expression increases activity multiple interactions |
ISO |
phenanthrene results in increased expression of CAT protein phenanthrene results in increased activity of CAT protein [phenanthrene co-treated with fluorene] results in increased activity of CAT protein |
CTD |
PMID:20238386 PMID:32856796 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression multiple interactions |
ISO |
phenanthrene results in decreased expression of CCNA2 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in decreased expression of CCNA2 protein |
CTD |
PMID:28803881 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CCND1 protein phenanthrene results in increased expression of CCND1 protein |
CTD |
PMID:28803881 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions increases expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CDK2 protein phenanthrene results in increased expression of CDK2 protein |
CTD |
PMID:28803881 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein |
CTD |
PMID:28710019 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein phenanthrene results in increased expression of CYP19A1 protein |
CTD |
PMID:28803881 |
|
NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases metabolic processing increases oxidation increases expression |
ISO EXP |
[CYP1A1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]; CYP1A1 protein results in increased metabolism of and results in increased activity of phenanthrene; GSTM1 gene polymorphism promotes the reaction [CYP1A1 gene polymorphism results in increased metabolism of phenanthrene] phenanthrene results in increased activity of CYP1A1 protein phenanthrene results in increased expression of CYP1A1 mRNA; phenanthrene results in increased expression of CYP1A1 protein |
CTD |
PMID:15566942 PMID:16906435 PMID:17035385 PMID:19766613 PMID:27137136 PMID:28710019 PMID:30980910 PMID:31181217 PMID:32890658 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity multiple interactions increases oxidation increases expression |
ISO |
phenanthrene results in increased activity of CYP1A2 protein [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA; CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene phenanthrene results in increased expression of CYP1A2 mRNA; phenanthrene results in increased expression of CYP1A2 protein |
CTD |
PMID:7750161 PMID:8001243 PMID:19766613 PMID:27137136 PMID:31181217 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions decreases metabolic processing increases oxidation increases expression |
ISO |
[CYP1B1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; CYP1B1 protein results in increased metabolism of and results in increased activity of phenanthrene; phenanthrene binds to and results in decreased activity of CYP1B1 protein CYP1B1 gene polymorphism results in decreased metabolism of phenanthrene phenanthrene results in increased expression of CYP1B1 mRNA |
CTD |
PMID:15566942 PMID:17035385 PMID:19563207 PMID:19766613 PMID:27137136 PMID:32890658 More...
|
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases oxidation multiple interactions affects binding |
ISO |
CYP2A13 protein results in increased oxidation of phenanthrene [CYP2A13 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol phenanthrene binds to CYP2A13 protein |
CTD |
PMID:27137136 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression multiple interactions |
ISO |
phenanthrene results in increased expression of CYP2B10 mRNA; phenanthrene results in increased expression of CYP2B10 protein NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 protein] |
CTD |
PMID:31181217 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
phenanthrene results in increased expression of CYP2B6 mRNA |
CTD |
PMID:31181217 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases metabolic processing |
ISO |
CYP2D6 protein results in increased metabolism of phenanthrene |
CTD |
PMID:9429232 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
CYP2E1 protein results in increased metabolism of and results in increased activity of phenanthrene |
CTD |
PMID:19766613 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
phenanthrene results in increased expression of EGR1 protein |
CTD |
PMID:15342960 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression |
ISO |
phenanthrene results in increased expression of EIF4E mRNA |
CTD |
PMID:34453960 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; phenanthrene analog binds to and results in decreased activity of ESR1 protein; phenanthrene binds to and results in increased activity of ESR1 protein |
CTD |
PMID:12672240 PMID:30980910 PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding |
ISO |
phenanthrene analog binds to ESR2 protein |
CTD |
PMID:12672240 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Foxp3 |
forkhead box P3 |
decreases expression |
EXP |
phenanthrene results in decreased expression of FOXP3 mRNA; phenanthrene results in decreased expression of FOXP3 protein |
CTD |
PMID:31456356 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
EXP |
phenanthrene results in decreased expression of GJB1 protein |
CTD |
PMID:25268939 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
phenanthrene results in increased expression of GSR protein |
CTD |
PMID:20238386 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
increases expression |
ISO |
phenanthrene results in increased expression of GSTA1 mRNA |
CTD |
PMID:32890658 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions affects metabolic processing |
ISO |
GSTM1 gene polymorphism promotes the reaction [CYP1A1 gene polymorphism results in increased metabolism of phenanthrene] GSTM1 protein affects the metabolism of phenanthrene |
CTD |
PMID:17035385 PMID:22674470 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
multiple interactions increases expression |
ISO |
NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of GSTM3 mRNA] |
CTD |
PMID:31181217 |
|
NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
phenanthrene results in increased expression of ICAM1 protein |
CTD |
PMID:22313677 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
ISO |
phenanthrene results in increased expression of IER3 mRNA |
CTD |
PMID:22579512 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ighe |
immunoglobulin heavy constant epsilon |
affects expression increases expression |
ISO |
phenanthrene affects the expression of IGHE mRNA alternative form phenanthrene results in increased expression of IGHE mRNA; phenanthrene results in increased expression of IGHE protein |
CTD |
PMID:9070347 |
|
|
|
G |
Il10 |
interleukin 10 |
decreases expression |
EXP |
phenanthrene results in decreased expression of IL10 mRNA; phenanthrene results in decreased expression of IL10 protein |
CTD |
PMID:31456356 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
phenanthrene results in increased expression of IL6 mRNA; phenanthrene results in increased expression of IL6 protein [fluorene co-treated with phenanthrene] results in increased expression of IL6 mRNA; [fluorene co-treated with phenanthrene] results in increased expression of IL6 protein |
CTD |
PMID:31456356 PMID:32856796 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lgals1 |
galectin 1 |
increases expression |
ISO |
phenanthrene results in increased expression of LGALS1 mRNA |
CTD |
PMID:22579512 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
decreases expression |
ISO |
phenanthrene results in decreased expression of NDC80 mRNA |
CTD |
PMID:22579512 |
|
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein |
CTD |
PMID:30980910 |
|
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
|
|
G |
Nlgn1 |
neuroligin 1 |
decreases expression |
ISO |
phenanthrene results in decreased expression of NLGN1 mRNA |
CTD |
PMID:34453960 |
|
NCBI chr 2:108,256,236...109,181,530
Ensembl chr 2:108,257,824...109,002,464
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
EXP ISO |
phenanthrene results in increased activity of NQO1 protein phenanthrene results in increased expression of NQO1 mRNA |
CTD |
PMID:16906435 PMID:31181217 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
phenanthrene binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity multiple interactions |
ISO |
phenanthrene results in increased activity of NR1I3 protein NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 protein]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP3A11 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of GSTM3 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of SULT2A1 mRNA]; NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of UGT1A1 mRNA] |
CTD |
PMID:28927721 PMID:31181217 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Pah |
phenylalanine hydroxylase |
decreases expression |
ISO |
phenanthrene results in decreased expression of PAH mRNA |
CTD |
PMID:22579512 |
|
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
phenanthrene results in increased cleavage of PARP1 protein |
CTD |
PMID:21132278 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
phenanthrene inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased activity of PGR protein] |
CTD |
PMID:26022396 |
|
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions decreases expression |
ISO |
phenanthrene affects the reaction [Tretinoin results in decreased expression of POU5F1 protein] phenanthrene results in decreased expression of POU5F1 protein |
CTD |
PMID:21111795 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Rhoc |
ras homolog family member C |
increases expression |
ISO |
phenanthrene results in increased expression of RHOC mRNA |
CTD |
PMID:22579512 |
|
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
|
|
G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
multiple interactions decreases expression |
ISO |
Sirolimus inhibits the reaction [phenanthrene results in decreased expression of SHANK3 mRNA] |
CTD |
PMID:34453960 |
|
NCBI chr 7:120,568,707...120,630,796
Ensembl chr 7:120,570,402...120,630,374
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
phenanthrene results in increased expression of SOD2 protein |
CTD |
PMID:20238386 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases expression multiple interactions |
ISO |
phenanthrene results in increased expression of SULT2A1 mRNA NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of SULT2A1 mRNA] |
CTD |
PMID:31181217 |
|
NCBI chr 1:75,451,178...75,508,142
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
phenanthrene results in decreased expression of TGFB1 mRNA; phenanthrene results in decreased expression of TGFB1 protein |
CTD |
PMID:31456356 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
phenanthrene results in increased expression of TIMP1 mRNA |
CTD |
PMID:22579512 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
[fluorene co-treated with phenanthrene] results in increased expression of TNF mRNA; [fluorene co-treated with phenanthrene] results in increased expression of TNF protein; TNF protein promotes the reaction [phenanthrene results in increased expression of CXCL8 mRNA] phenanthrene results in increased expression of TNF mRNA; phenanthrene results in increased expression of TNF protein |
CTD |
PMID:18434080 PMID:31456356 PMID:32856796 PMID:34453960 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression multiple interactions |
ISO |
phenanthrene results in increased expression of UGT1A1 mRNA NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of UGT1A1 mRNA] |
CTD |
PMID:31181217 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions |
ISO |
[phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of UGT1A6 mRNA |
CTD |
PMID:15566942 |
|
NCBI chr 9:88,747,229...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Ano1 |
anoctamin 1 |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Calcium results in increased activity of ANO1 protein] |
CTD |
PMID:25573456 |
|
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP ISO |
9-phenanthrol inhibits the reaction [Metribolone binds to AR protein] 9-phenanthrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] |
CTD |
PMID:3695475 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
9-phenanthrol results in increased expression of C3 mRNA |
CTD |
PMID:22989670 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases abundance multiple interactions |
ISO |
CYP1A1 protein results in increased abundance of 9-phenanthrol [CYP1A1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol |
CTD |
PMID:27137136 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases abundance |
ISO |
[CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol CYP1A2 protein results in increased abundance of 9-phenanthrol |
CTD |
PMID:27137136 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases abundance multiple interactions |
ISO |
CYP1B1 protein results in increased abundance of 9-phenanthrol [CYP1B1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol |
CTD |
PMID:27137136 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
multiple interactions increases abundance |
ISO |
[CYP2A13 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol CYP2A13 protein results in increased abundance of 9-phenanthrol |
CTD |
PMID:27137136 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
9-phenanthrol binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
ESR2 protein binds to 9-phenanthrol 9-phenanthrol inhibits the reaction [ESR2 protein binds to Estradiol] |
CTD |
PMID:22989670 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Lipopolysaccharides results in increased expression of FTH1 mRNA] |
CTD |
PMID:27246103 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gcg |
glucagon |
multiple interactions |
EXP |
9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein] |
CTD |
PMID:29098165 |
|
NCBI chr 3:47,113,914...47,122,929
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of ICAM1 protein] |
CTD |
PMID:28214884 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ins1 |
insulin 1 |
multiple interactions increases secretion |
EXP |
9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; 9-phenanthrol inhibits the reaction [Glucose results in increased secretion of INS1 protein] 9-phenanthrol results in increased secretion of INS1 protein |
CTD |
PMID:29098165 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression |
ISO |
9-phenanthrol results in decreased expression of JAG1 mRNA |
CTD |
PMID:22989670 |
|
NCBI chr 3:124,406,794...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Lipopolysaccharides affects the localization of NFATC1 protein] |
CTD |
PMID:27246103 |
|
NCBI chr18:74,046,421...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; 9-phenanthrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:27246103 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
9-phenanthrol binds to and affects the activity of NR1I2 protein 9-phenanthrol binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
9-phenanthrol results in increased expression of NRIP1 mRNA |
CTD |
PMID:22989670 |
|
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
9-phenanthrol binds to and affects the activity of PPARG protein 9-phenanthrol binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Scn5a |
sodium voltage-gated channel alpha subunit 5 |
decreases activity |
ISO |
9-phenanthrol results in decreased activity of SCN5A protein mutant form |
CTD |
PMID:30153324 |
|
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of SELE protein] |
CTD |
PMID:28214884 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
9-phenanthrol binds to and results in increased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
9-phenanthrol binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
multiple interactions decreases activity |
ISO |
9-phenanthrol inhibits the reaction [Arsenic Trioxide results in increased expression of TRPM4 protein]; 9-phenanthrol inhibits the reaction [Glutamic Acid results in increased activity of TRPM4 protein]; 9-phenanthrol inhibits the reaction [Hydrogen Peroxide results in increased expression of TRPM4 protein] 9-phenanthrol results in decreased activity of TRPM4 protein |
CTD |
PMID:25047048 PMID:28214884 PMID:31054354 PMID:34335274 |
|
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
|
|
G |
Trpm5 |
transient receptor potential cation channel, subfamily M, member 5 |
decreases activity |
ISO |
9-phenanthrol results in decreased activity of TRPM5 protein |
CTD |
PMID:18297105 |
|
NCBI chr 1:198,254,956...198,277,824
Ensembl chr 1:198,255,723...198,277,654
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
9-phenanthrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of VCAM1 protein] |
CTD |
PMID:28214884 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|